首页> 美国卫生研究院文献>Infection Chemotherapy >Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities
【2h】

Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities

机译:中东医疗机构的呼吸综合征感染控制和预防指南

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Middle East Respiratory Syndrome (MERS) is an acute viral respiratory illness with high mortality caused by a new strain of betacoronavirus (MERS-CoV). Since the report of the first patient in Saudi Arabia in 2012, large-scale outbreaks through hospital-acquired infection and inter-hospital transmission have been reported. Most of the patients reported in South Korea were also infected in hospital settings. Therefore, to eliminate the spread of MERS-CoV, infection prevention and control measures should be implemented with rigor. The present guideline has been drafted on the basis of the experiences of infection control in the South Korean hospitals involved in the recent MERS outbreak and on domestic and international infection prevention and control guidelines. To ensure efficient MERS-CoV infection prevention and control, care should be taken to provide comprehensive infection control measures including contact control, hand hygiene, personal protective equipment, disinfection, and environmental cleaning.
机译:中东呼吸综合症(MERS)是一种由新的β冠状病毒(MERS-CoV)株引起的急性病毒性呼吸道疾病,死亡率高。自2012年在沙特阿拉伯报告第一例患者以来,已有报道称因医院获得性感染和医院间传播而大规模爆发。韩国报告的大多数患者在医院环境中也受到感染。因此,为消除MERS-CoV的传播,应严格执行感染预防和控制措施。本指南是根据最近发生MERS疫情的韩国医院的感染控制经验以及国内外感染预防和控制指南起草的。为确保有效地预防和控制MERS-CoV感染,应注意提供全面的感染控制措施,包括接触控制,手卫生,个人防护设备,消毒和环境清洁。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号